OIA
AYTU icon

Optimum Investment Advisors’s AYTU BioPharma AYTU Stock Holding History

Optimum Investment Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed – – 765
2022
Q3 		$0 Hold
3
– – ﹤0.01% 811
2022
Q2 		$0 Hold
3
– – ﹤0.01% 829
2022
Q1 		$0 Hold
3
– – ﹤0.01% 833
2021
Q4 		$0 Hold
3
– – ﹤0.01% 827
2021
Q3 		$0 Hold
3
– – ﹤0.01% 830
2021
Q2 		$0 Hold
3
– – ﹤0.01% 909
2021
Q1 		$0 Hold
3
– – ﹤0.01% 913
2020
Q4 		$0 Hold
3
– – ﹤0.01% 873
2020
Q3 		$1K Hold
3
– – ﹤0.01% 840
2020
Q2 		$1K Buy
+3
New +$908 ﹤0.01% 837

Other funds holding AYTU

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Optimum Investment Advisors's AYTU Position: Q4 2022 in Review

Optimum Investment Advisors sold out of AYTU BioPharma (AYTU) in Q4 2022, closing a stake of 3 shares.

Optimum Investment Advisors first reported a position in AYTU in Q2 2020 and held it in 10 quarters. The position peaked at $1K in Q3 2020. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

  • Optimum Investment Advisors reported no remaining AYTU BioPharma position as of Q4 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 3 AYTU BioPharma shares in Q4 2022.
  • Optimum Investment Advisors first reported a position in AYTU BioPharma in Q2 2020 and held it in 10 quarters.
  • Optimum Investment Advisors's AYTU BioPharma position peaked at $1K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.